Synonym |
Thai / English name |
Part Used : -Activity : CYP2B6 INDUCTIONSolvent/Active Compound : BST204Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : -Duration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : The inhibitory potency of BST204 and its bioactive ginsenosides, R-Rg3, S-Rg3, R-Rh2 and S-Rh2, was determined using a nine - CYP isozyme cocktail assay in pooled human liver microsomes. Combining nine specific substrates for each CYP in cocktails is particularly useful because it is possible to measure multiple CYP activities in the same microsomal incubation. In brief, the 90-microlitre incubation mixture, including pooled human liver microsomes (final concentration 0.25 mg/mL), 0.1 M phosphate buffer, each P450-selective substrate cocktail set, and test compounds (0-5 micromolars) was pre-incubated for 5 min at 37 degrees celsius.
Part Used : -Activity : CYP2B6 INDUCTIONSolvent/Active Compound : BST204 (a purified dry extract of ginseng)Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : 0.1 microgram/mLDuration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Induction potential of 0.1 microgram/mL BST204 on activities of CYP1A2, CYP2B6 and CYP3A4/5 in three different lots of cryopreserved human hepatocytes. Fold increase enzyme activity in each CYP were 1.00 +/- 0.0588, 0.984 +/- 0.113 and 0.922 +/- 0.109, respectively.
Part Used : -Activity : CYP2B6 INDUCTIONSolvent/Active Compound : BST204 (a purified dry extract of ginseng)Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : 1 microgram/mLDuration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Induction potential of 0.1 microgram/mL BST204 on activities of CYP1A2, CYP2B6 and CYP3A4/5 in three different lots of cryopreserved human hepatocytes. Fold increase enzyme activity in each CYP were 1.01 +/- 0.188, 0.975 +/- 0.0915 and 0.856 +/- 0.148, respectively.
Part Used : -Activity : CYP2B6 INDUCTIONSolvent/Active Compound : BST204 (a purified dry extract of ginseng)Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : 10 microgram/mLDuration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Induction potential of 10 microgram/mL BST204 on activities of CYP1A2, CYP2B6 and CYP3A4/5 in three different lots of cryopreserved human hepatocytes. Fold increase enzyme activity in each each CYP were 1.08 +/- 0.148, 0.940 +/- 0.198 and 0.976 +/- 0.190, respectively.
Part Used : -Activity : CYP2B6 INDUCTIONSolvent/Active Compound : BST204 (a purified dry extract of ginseng)Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : 0.1 microgram/mLDuration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Induction potential of 0.1 microgram/mL ginsenoside S-Rg3 on activities of CYP1A2, CYP2B6 and CYP3A4/5 in three different lots of cryopreserved human hepatocytes. Fold increase enzyme activity in each CYP were 1.02 +/- 0.0311, 1.11 +/- 0.212, and 0.988 +/- 0.0181, respectively.
Part Used : -Activity : CYP2B6 INDUCTIONSolvent/Active Compound : Ginsenoside S-Rg3Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : 1 microgram/mLDuration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Induction potential of 1 microgram/mL ginsenoside S-Rg3 on activities of CYP1A2, CYP2B6 and CYP3A4/5 in three different lots of cryopreserved human hepatocytes. Fold increase enzyme activity in each CYP were 1.02 +/- 0.0618, 1.13 +/- 0.0754, and 0.979 +/- 0.00715, respectively.
Part Used : -Activity : CYP2B6 INDUCTIONSolvent/Active Compound : Ginsenoside S-Rg3Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : 10 microgram/mLDuration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Induction potential of 10 microgram/mL ginsenoside S-Rg3 on activities of CYP1A2, CYP2B6 and CYP3A4/5 in three different lots of cryopreserved human hepatocytes. Fold increase enzyme activity in each CYP were 0.940 +/- 0.0522, 1.08 +/- 0.150, and 0.979 +/- 0.0980, respectively.
Part Used : -Activity : CYP2B6 INDUCTIONSolvent/Active Compound : Ginsenoside S-Rg3Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : 0.1 microgram/mLDuration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Induction potential of 0.1 microgram/mL ginsenoside S-Rg3 on activities of CYP1A2, CYP2B6 and CYP3A4/5 in three different lots of cryopreserved human hepatocytes. Fold increase enzyme activity in each CYP were 0.989 +/- 0.112, 1.03 +/- 0.164, and 0.872 +/- 0.0500, respectively.
Part Used : -Activity : CYP2B6 INDUCTIONSolvent/Active Compound : Ginsenoside S-Rg3Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : 1 microgram/mLDuration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Induction potential of 1 microgram/mL ginsenoside S-Rg3 on activities of CYP1A2, CYP2B6 and CYP3A4/5 in three different lots of cryopreserved human hepatocytes. Fold increase enzyme activity in each CYP were 0.989 +/- 0.0884, 1.04 +/- 0.144, and 0.849 +/- 0.0706, respectively.
Part Used : -Activity : CYP2B6 INDUCTIONSolvent/Active Compound : Ginsenoside S-Rg3Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : 10 microgram/mLDuration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Induction potential of 10 microgram/mL ginsenoside S-Rg3 on activities of CYP1A2, CYP2B6 and CYP3A4/5 in three different lots of cryopreserved human hepatocytes. Fold increase enzyme activity in each CYP were 1.09 +/- 0.0739, 1.03 +/- 0.0516, and 0.846 +/- 0.0438, respectively.